Standard BioTools to Participate in Upcoming Investor Conferences
February 27 2025 - 3:01PM
Standard BioTools Inc. (NASDAQ: LAB) today announced that company
management will participate in the following investor conferences:
- TD Cowen’s
45th Annual Healthcare Conference - March
3rd –
5th, 2025 Presenting
on Monday, March 3, 2025, at 3:10 p.m. ET
- 2025
Leerink Partners Global Healthcare Conference - March
9th –
12th, 2025Participating
in investor meetings on March 12th
-
KeyBanc’s 5th Annual Healthcare Forum –
March 18th &
19th, 2025Presenting on
Wednesday, March 19, 2025, at 4:30 p.m. ET
Presentations will be webcast live and available on the Investor
Relations page of the Company’s website at Events &
Presentations. A recording will be archived and available on the
Standard BioTools Investor Relations page at
investors.standardbio.com.
About Standard BioTools Inc.
Standard BioTools Inc. (Nasdaq: LAB), has an established
portfolio of essential, standardized next-generation technologies
that help biomedical researchers develop medicines faster and
better. As a leading solutions provider, the company provides
reliable and repeatable insights in health and disease using its
proprietary SomaScan, mass cytometry and microfluidics
technologies, which help transform scientific discoveries into
better patient outcomes. Standard BioTools works with leading
academic, government, pharmaceutical, biotechnology, plant and
animal research and clinical laboratories worldwide, focusing on
the most pressing needs in translational and clinical research,
including oncology, immunology and immunotherapy. Learn more at
standardbio.com or connect with us on X, Facebook®, LinkedIn, and
YouTube™.
For Research Use Only. Not for use in diagnostic procedures.
Limited Use Label License and other terms may apply:
standardbio.com/legal/salesterms.Patent and License Information:
standardbio.com/legal/notices. Trademarks:
standardbio.com/legal/trademarks. Any other trademarks are the sole
property of their respective owners. ©2025 Standard BioTools Inc.
(f.k.a. Fluidigm Corporation). All rights reserved.
Investor Contact
David Holmesir@standardbio.com
Standard BioTools (NASDAQ:LAB)
Historical Stock Chart
From Jan 2025 to Feb 2025
Standard BioTools (NASDAQ:LAB)
Historical Stock Chart
From Feb 2024 to Feb 2025
